Based on 3 analysts offering 12 month price targets for Genmab A
Min Forecast
$40.00+12.45%
Avg Forecast
$41.67+17.14%
Max Forecast
$43.00+20.89%
Should I buy or sell GMAB stock?
Based on 3 analysts offering ratings for Genmab A.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GMAB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates GMAB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their GMAB stock forecasts and price targets.
Is Genmab A Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: GMAB) stock is to Strong Buy GMAB stock.
Out of 3 analysts, 2 (66.67%) are recommending GMAB as a Strong Buy, 1 (33.33%) are recommending GMAB as a Buy, 0 (0%) are recommending GMAB as a Hold, 0 (0%) are recommending GMAB as a Sell, and 0 (0%) are recommending GMAB as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year GMAB price target, the average GMAB price target is $41.67, with the highest GMAB stock price forecast at $43.00 and the lowest GMAB stock price forecast at $40.00.
On average, Wall Street analysts predict that Genmab A's share price could reach $41.67 by Sep 14, 2027. The average Genmab A stock price prediction forecasts a potential upside of 17.14% from the current GMAB share price of $35.57.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.